Here’s an outrageous question for you: Does psychotherapy work? Of course it does, you say, particularly cognitive behavior therapy (CBT). CBT has become so mainstream that Forbes magazine devoted its April 2007 cover article to it.
Read More
Over 30 years of practicing and teaching psychotherapy with a range of patients, Dr. Arnold Robbins has developed an integrated approach that can be individualized and is useful for his patients.
Read More
How do you combine CBT and psychopharm? What techniques are helpful for reducing hallucinations? Do you use CBT specifically to improve adherence to medications? These questions and more are addressed.
Read More
About 20% of patients with cancer develop major depression, and at least 60% present with significant symptoms of sadness and anxiety not severe enough to meet criteria for a DSM-4 disorder.
Read More
In 2005, the FDA issued a health advisory saying that antipsychotics appear to increase the risk of death in elderly patients with dementia. That advisory was based on data from placebo-controlled trials of antipsychotics conducted by industry. Now, a new study based on a completely different, and much larger, dataset, appears to confirm these dangers.
Read More
In a provocative study, rates of Ritalin prescriptions in Canada from 1994-2000 were compared with rates of divorce. The study focused on children ages 2-7, and found that in families that stayed intact during the study period, 3.3% of children were prescribed Ritalin.
Read More
One of the final major questions that the NIMH-funded CATIE trials promised to answer was whether atypical antipsychotics are better at improving cognition in schizophrenia than conventional agents, as some smaller studies implied.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.